- Home
- DYN vs VRE Comparison
DYN vs VRE Comparison
Compare DYN & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- VRE
- Stock Information
- Founded
- DYN 1984
- VRE 1949
- Country
- DYN United States
- VRE United States
- Employees
- DYN N/A
- VRE N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- VRE Real Estate Investment Trusts
- Sector
- DYN Health Care
- VRE Real Estate
- Exchange
- DYN Nasdaq
- VRE Nasdaq
- Market Cap
- DYN 1.4B
- VRE 1.4B
- IPO Year
- DYN 2020
- VRE 1994
- Fundamental
- Price
- DYN $9.57
- VRE $15.07
- Analyst Decision
- DYN Strong Buy
- VRE Buy
- Analyst Count
- DYN 15
- VRE 4
- Target Price
- DYN $43.60
- VRE $18.50
- AVG Volume (30 Days)
- DYN 2.7M
- VRE 506.8K
- Earning Date
- DYN 08-11-2025
- VRE 07-23-2025
- Dividend Yield
- DYN N/A
- VRE 2.15%
- EPS Growth
- DYN N/A
- VRE N/A
- EPS
- DYN N/A
- VRE N/A
- Revenue
- DYN N/A
- VRE $279,630,000.00
- Revenue This Year
- DYN N/A
- VRE $2.86
- Revenue Next Year
- DYN N/A
- VRE $3.96
- P/E Ratio
- DYN N/A
- VRE N/A
- Revenue Growth
- DYN N/A
- VRE 3.92
- 52 Week Low
- DYN $6.36
- VRE $14.12
- 52 Week High
- DYN $47.45
- VRE $18.85
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- VRE 45.35
- Support Level
- DYN $10.00
- VRE $14.51
- Resistance Level
- DYN $10.74
- VRE $15.27
- Average True Range (ATR)
- DYN 0.88
- VRE 0.29
- MACD
- DYN -0.48
- VRE -0.01
- Stochastic Oscillator
- DYN 0.53
- VRE 40.62
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.